Exploration of lung mycobiome in the patients with non-small-cell lung cancer

被引:13
|
作者
Zhao, Yiming [1 ,2 ]
Yi, Junqi [1 ,3 ]
Xiang, Juanjuan [3 ,4 ,5 ]
Jia, Wei [6 ]
Chen, Anqi [1 ]
Chen, Liyu [2 ]
Zheng, Leliang [4 ,5 ]
Zhou, Wen [4 ,5 ]
Wu, Minghua [4 ,5 ]
Yu, Zheng [2 ]
Tang, Jingqun [1 ,3 ]
机构
[1] Cent South Univ, Xiangya Hosp 2, Dept Thorac Surg, Changsha, Hunan, Peoples R China
[2] Cent South Univ, Sch Basic Med Sci, Dept Microbiol, Changsha, Hunan, Peoples R China
[3] Hunan Key Lab Early Diag & Precise Treatment Lung, Changsha, Hunan, Peoples R China
[4] Cent South Univ, NHC Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China
[5] Cent South Univ, Canc Res Inst, Sch Basic Med Sci, Chinese Minist Educ,Key Lab Carcinogenesis & Canc, Changsha, Hunan, Peoples R China
[6] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon Tong, Peoples R China
基金
中国国家自然科学基金;
关键词
Non-small-cell lung cancer; Mycobiome; Alternaria arborescens; ACETALDEHYDE PRODUCTION; MICROBIOME; COMMUNITY; INFLAMMATION; INFECTIONS; IMMUNITY;
D O I
10.1186/s12866-023-02790-4
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
As the Human Microbiome Project (HMP) progresses, the relationship between microbes and human health has been receiving increasing attention. A growing number of reports support the correlation between cancer and microbes. However, most studies have focused on bacteria, rather than fungal communities. In this study, we studied the alteration in lung mycobiome in patients with non-small-cell lung cancer (NSCLC) using metagenomic sequencing and qPCR. The higher fungal diversity and more complex network were observed in the patients with NSCLC. In addition, Alternaria arborescens was found as the most relevant fungus to NSCLC, and the enrichment of it in cancerous tissue was also detected. This study proposes that the changes in fungal communities may be closely related to lung cancer, and provides insights into further exploration the relationship between lung cancer and fungi.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Impact of different patterns of metastasis in non-small-cell lung cancer patients
    da Silva, Larissy Machado
    da Silva, Gustavo Telles
    Bergmann, Anke
    Costa, Guilherme Jorge
    Zamboni, Mauro Musa
    Santos Thuler, Luiz Claudio
    FUTURE ONCOLOGY, 2021, 17 (07) : 775 - 782
  • [42] Risk factors for brain metastases in patients with non-small-cell lung cancer
    An, Ning
    Jing, Wang
    Wang, Haoyi
    Li, Ji
    Liu, Yang
    Yu, Jinming
    Zhu, Hui
    CANCER MEDICINE, 2018, 7 (12): : 6357 - 6364
  • [43] Survival outcomes in patients with non-small-cell lung cancer treated with erlotinib
    McGrath, Alexandria C.
    Sandhu, Geeta
    Walpole, Euan
    McCaffrey, Elizabeth
    Hollingworth, Samantha A.
    ANTI-CANCER DRUGS, 2018, 29 (08) : 786 - 790
  • [44] Therapy of non-small-cell lung cancer (NSCLC) in patients with HIV infection
    Spina, M
    Sandri, S
    Serraino, D
    Gobitti, C
    Fasan, M
    Sinicco, A
    Garavelli, PL
    Ridolfo, A
    Tirelli, U
    ANNALS OF ONCOLOGY, 1999, 10 : 87 - 90
  • [45] Nivolumab-refractory patients with advanced non-small-cell lung cancer
    Costantini, A.
    Fallet, V.
    Corny, J.
    Friard, S.
    Chouaid, C.
    Duchemann, B.
    Giroux-Leprieur, E.
    Taillade, L.
    Doucet, L.
    Brosseau, S.
    Wislez, M.
    Tredaniel, J.
    Cadranel, J.
    LUNG CANCER, 2019, 130 : 128 - 134
  • [46] Trends in chemotherapy for elderly patients with advanced non-small-cell lung cancer
    Kim, Young Hak
    Yoh, Kiyotaka
    Niho, Seiji
    Goto, Koichi
    Ohmatsu, Hironobu
    Kubota, Kaoru
    Nishiwaki, Yutaka
    RESPIRATORY MEDICINE, 2010, 104 (03) : 434 - 439
  • [47] Patients' preferences for chemotherapy in non-small-cell lung cancer: A systematic review
    Blinman, Prunella
    Alam, Mahmood
    Duric, Vlatka
    McLachlan, Sue-Anne
    Stockler, Martin R.
    LUNG CANCER, 2010, 69 (02) : 141 - 147
  • [48] Treatment and outcomes of non-small-cell lung cancer patients with high comorbidity
    Rios, Jorge
    Gosain, Rahul
    Goulart, Bernardo H. L.
    Huang, Bin
    Oechsli, Margaret N.
    McDowell, Jaclyn K.
    Chen, Quan
    Tucker, Thomas
    Kloecker, Goetz H.
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 167 - 175
  • [49] Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets
    Gong, Jiali
    Hu, Shumin
    Shan, Qianyun
    Qin, Jing
    Han, Na
    Xie, Fajun
    Lu, Hongyang
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [50] sLAG-3 in non-small-cell lung cancer patients' serum
    He, Yayi
    Wang, Yan
    Zhao, Sha
    Zhao, Chao
    Zhou, Caicun
    Hirsch, Fred R.
    ONCOTARGETS AND THERAPY, 2018, 11 : 4781 - 4784